MyCell® Products include human induced pluripotent stem cells (iPSCs) and iPSC-derived cells manufactured from customer-defined donor samples. iPSC technology offers unparalleled access to human biology and opportunities to advance the fields of disease research, drug discovery, and toxicity testing.
Created from adult tissue (e.g. blood or skin), iPSCs have the potential to differentiate into any of the cell types in the human body. Importantly, iPSC technology allows the creation of pluripotent stem cells from any individual or donor population using non-invasive methods, thereby providing a means to model genetic diversity and disease phenotypes in vitro.
MyCell Products include iPSC reprogramming, genetic engineering, and terminal cell differentiation.
Quick Search
Products 
